These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11092707)

  • 1. HIV-associated tuberculosis in the era of HAART.
    Pozniak A
    Int J Tuberc Lung Dis; 2000 Nov; 4(11):993-4. PubMed ID: 11092707
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of highly active antiretroviral therapy on incidence and management of human immunodeficiency virus-related opportunistic infections.
    Hung CC; Chang SC
    J Antimicrob Chemother; 2004 Nov; 54(5):849-53. PubMed ID: 15456733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TB and HIV: joint problems, joint solutions?
    Elzinga G; Nunn P
    Bull World Health Organ; 2002; 80(6):469-70. PubMed ID: 12132004
    [No Abstract]   [Full Text] [Related]  

  • 5. Tuberculosis epidemics driven by HIV: is prevention better than cure?
    Currie CS; Williams BG; Cheng RC; Dye C
    AIDS; 2003 Nov; 17(17):2501-8. PubMed ID: 14600522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Issues in the management of HIV-related tuberculosis.
    Burman WJ
    Clin Chest Med; 2005 Jun; 26(2):283-94, vi-vii. PubMed ID: 15837111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculosis and HIV infection.
    Uragoda CG
    Ceylon Med J; 1996 Mar; 41(1):5-6. PubMed ID: 8754606
    [No Abstract]   [Full Text] [Related]  

  • 8. Low-income countries: where are we going with TB-HIV in 2009?
    Mwinga A
    Int J Tuberc Lung Dis; 2009 Jul; 13(7):797-8. PubMed ID: 19555525
    [No Abstract]   [Full Text] [Related]  

  • 9. Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy.
    Dheda K; Lampe FC; Johnson MA; Lipman MC
    J Infect Dis; 2004 Nov; 190(9):1670-6. PubMed ID: 15478074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High coverage with HAART is required to substantially reduce the number of deaths from tuberculosis: system dynamics simulation.
    Atun RA; Lebcir RM; Drobniewski F; McKee M; Coker RJ
    Int J STD AIDS; 2007 Apr; 18(4):267-73. PubMed ID: 17509178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis in HIV-infected patients: a comprehensive review.
    Aaron L; Saadoun D; Calatroni I; Launay O; Mémain N; Vincent V; Marchal G; Dupont B; Bouchaud O; Valeyre D; Lortholary O
    Clin Microbiol Infect; 2004 May; 10(5):388-98. PubMed ID: 15113314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HIV and tuberculosis: new perspectives for diagnosis and treatment].
    Zellweger JP
    Rev Med Suisse; 2006 Nov; 2(87):2616-9. PubMed ID: 17343152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis control in South Africa--will HAART help?
    Lawn SD; Wood R
    S Afr Med J; 2006 Jun; 96(6):502-4. PubMed ID: 16841129
    [No Abstract]   [Full Text] [Related]  

  • 14. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
    Ives NJ; Gazzard BG; Easterbrook PJ
    J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy.
    Sacktor N
    J Neurovirol; 2002 Dec; 8 Suppl 2():115-21. PubMed ID: 12491162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylaxis and treatment of opportunistic infection in patients on HAART.
    Tantisiriwat W; Powderly WG
    AIDS Read; 1999; 9(2):122-30. PubMed ID: 12728894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opportunistic infections in the era of highly active antiretroviral therapy.
    Ferri RS
    Lippincotts Prim Care Pract; 2000; 4(1):20-8. PubMed ID: 11022517
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes in the incidence of tuberculosis in a cohort of HIV-seroconverters before and after the introduction of HAART.
    Muga R; Ferreros I; Langohr K; de Olalla PG; Del Romero J; Quintana M; Alastrue I; Belda J; Tor J; Pérez-Hoyos S; Del Amo J;
    AIDS; 2007 Nov; 21(18):2521-7. PubMed ID: 18025889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review editorial: prevention of tuberculosis in resource-poor countries with increasing access to highly active antiretroviral treatment.
    Apers L; Lynen L; Worodria W; Colebunders R
    Trop Med Int Health; 2005 Dec; 10(12):1209-14. PubMed ID: 16359399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urgent need for a new approach to the diagnosis of tuberculosis in developing countries in the decade of AIDS.
    L'Herminez RH
    Trop Geogr Med; 1993; 45(4):145-9. PubMed ID: 8236463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.